PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32726604-0	2020	Isoliquiritigenin protects against angiotensin II-induced fibrogenesis by inhibiting NF-kappaB/PPARgamma inflammatory pathway in human Tenon"s capsule fibroblasts.	isoliquiritigenin	0-17	angiotensinogen	Homo sapiens	35-49	
32726604-1	2020	PURPOSE: To examine the protective effects of Isoliquiritigenin (ISL) in angiotensin II (ANG II)-induced inflammation and fibrosis on Human Tenon"s capsule Fibroblasts (HTFs) and Mouse Peritoneal Macrophages (MPMs).	isoliquiritigenin	46-63	angiotensinogen	Homo sapiens	73-87	
32726604-1	2020	PURPOSE: To examine the protective effects of Isoliquiritigenin (ISL) in angiotensin II (ANG II)-induced inflammation and fibrosis on Human Tenon"s capsule Fibroblasts (HTFs) and Mouse Peritoneal Macrophages (MPMs).	isoliquiritigenin	65-68	angiotensinogen	Homo sapiens	73-87	
32726604-1	2020	PURPOSE: To examine the protective effects of Isoliquiritigenin (ISL) in angiotensin II (ANG II)-induced inflammation and fibrosis on Human Tenon"s capsule Fibroblasts (HTFs) and Mouse Peritoneal Macrophages (MPMs).	isoliquiritigenin	65-68	angiotensinogen	Homo sapiens	89-95	
30340829-0	2018	Isoliquiritigenin alleviated the Ang II-induced hypertensive renal injury through suppressing inflammation cytokines and oxidative stress-induced apoptosis via Nrf2 and NF-kappaB pathways.	isoliquiritigenin	0-17	angiotensinogen	Homo sapiens	33-39	
34655849-11	2021	Furthermore, drug response analysis implied that AGT expression was associated with isoliquiritigenins (ISL).	isoliquiritigenin	84-102	angiotensinogen	Homo sapiens	49-52	
34655849-11	2021	Furthermore, drug response analysis implied that AGT expression was associated with isoliquiritigenins (ISL).	isoliquiritigenin	104-107	angiotensinogen	Homo sapiens	49-52